ahlam1399
03-25-2016, 11:43 PM
BRIEF-Oxigene says receives European orphan drug designation for CA4P
* European commission has granted orphan drug designation to CA4P for treatment of gastro-entero-pancreatic neuroendocrine tumors
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e83db7f/sc/13/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=IQfmAZ5-Dz0:Y2856kOYj98:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=IQfmAZ5-Dz0:Y2856kOYj98:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=IQfmAZ5-Dz0:Y2856kOYj98:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=IQfmAZ5-Dz0:Y2856kOYj98:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=IQfmAZ5-Dz0:Y2856kOYj98:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/IQfmAZ5-Dz0
* European commission has granted orphan drug designation to CA4P for treatment of gastro-entero-pancreatic neuroendocrine tumors
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e83db7f/sc/13/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=IQfmAZ5-Dz0:Y2856kOYj98:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=IQfmAZ5-Dz0:Y2856kOYj98:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=IQfmAZ5-Dz0:Y2856kOYj98:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=IQfmAZ5-Dz0:Y2856kOYj98:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=IQfmAZ5-Dz0:Y2856kOYj98:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/IQfmAZ5-Dz0